Zdrowie i gospodarka · 30/07/2009

FDA Releases Draft Guidance on Genomic Biomarkers for Drug Response

The FDA has made available a draft guidance document outlining recommendations for the context, structure, and format of submissions for genomic biomarkers related to drug response, in an effort to standardize applications across regions and facilitate collaboration with regulatory authorities.